133 related articles for article (PubMed ID: 31870087)
1. Lipid accumulation product is a predictor of nonalcoholic fatty liver disease in childhood obesity.
Özcabı B; Demirhan S; Akyol M; Öztürkmen Akay H; Güven A
Korean J Pediatr; 2019 Dec; 62(12):450-455. PubMed ID: 31870087
[TBL] [Abstract][Full Text] [Related]
2. Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults.
Dai H; Wang W; Chen R; Chen Z; Lu Y; Yuan H
Nutr Metab (Lond); 2017; 14():49. PubMed ID: 28775758
[TBL] [Abstract][Full Text] [Related]
3. Is Lipid Accumulation Product Associated with an Atherogenic Lipoprotein Profile in Brazilian Subjects?
Cartolano FC; Pappiani C; Freitas MCP; Figueiredo Neto AM; Carioca AAF; Damasceno NRT
Arq Bras Cardiol; 2018 Apr; 110(4):339-347. PubMed ID: 29791572
[TBL] [Abstract][Full Text] [Related]
4. Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals.
Xia C; Li R; Zhang S; Gong L; Ren W; Wang Z; Li Q
Eur J Clin Nutr; 2012 Sep; 66(9):1035-8. PubMed ID: 22781025
[TBL] [Abstract][Full Text] [Related]
5. Lipid accumulation product is a valid predictor of hepatic steatosis and nonalcoholic fatty liver disease.
Huang Q; Tan X; Wu Q; Zhao H; Chen H; Yu X; Wang J; Huang X; Huang Y; Wei J; Wu F; Zhu H; Wang L
Biomark Med; 2024 Feb; 18(3):123-135. PubMed ID: 38456353
[No Abstract] [Full Text] [Related]
6. Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis.
Ebrahimi M; Seyedi SA; Nabipoorashrafi SA; Rabizadeh S; Sarzaeim M; Yadegar A; Mohammadi F; Bahri RA; Pakravan P; Shafiekhani P; Nakhjavani M; Esteghamati A
Lipids Health Dis; 2023 Mar; 22(1):41. PubMed ID: 36922815
[TBL] [Abstract][Full Text] [Related]
7. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Different Anthropometric Indicators for Screening for Nonalcoholic Fatty Liver Disease in Elderly Individuals.
Zhang Y; Li B; Liu N; Wang P; He J
Int J Endocrinol; 2021; 2021():6678755. PubMed ID: 33574841
[TBL] [Abstract][Full Text] [Related]
9. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
10. What is the appropriate strategy for diagnosing NAFLD using ultrasonography in obese children?
Lee JH; Jeong SJ
World J Pediatr; 2017 Jun; 13(3):248-254. PubMed ID: 28101773
[TBL] [Abstract][Full Text] [Related]
11. Association Between Lipid Accumulation Product and Mild Cognitive Impairment in Patients with Type 2 Diabetes.
Yu ZW; Li X; Wang Y; Fu YH; Gao XY
J Alzheimers Dis; 2020; 77(1):367-374. PubMed ID: 32804130
[TBL] [Abstract][Full Text] [Related]
12. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
13. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
Torun E; Aydın S; Gökçe S; Özgen İT; Donmez T; Cesur Y
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():92-8. PubMed ID: 25910377
[TBL] [Abstract][Full Text] [Related]
14. Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults.
Liu Y; Wang W
Lipids Health Dis; 2022 Jan; 21(1):8. PubMed ID: 35027066
[TBL] [Abstract][Full Text] [Related]
15. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study.
Koehler EM; Schouten JN; Hansen BE; Hofman A; Stricker BH; Janssen HL
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1201-4. PubMed ID: 23353640
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
Alkassabany YM; Farghaly AG; El-Ghitany EM
Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
[TBL] [Abstract][Full Text] [Related]
17. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
Li XD; Qiu BH; Su FC; Sun SX
Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
[TBL] [Abstract][Full Text] [Related]
18. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
[TBL] [Abstract][Full Text] [Related]
19. Lipid Accumulation Product and Index of Central Lipid Distributions for Subclinical Atherosclerosis in Perimenopausal/Menopausal Women.
Tongdee P; Ananwattanasuk T; Benjaoran F; Rattanathawornkiti K; Horpibulsuk J; Nimkuntod P
J Med Assoc Thai; 2016 Oct; 99 Suppl 7():S42-8. PubMed ID: 29901904
[TBL] [Abstract][Full Text] [Related]
20. The lipid accumulation product is a powerful tool to predict metabolic syndrome in undiagnosed Brazilian adults.
Nascimento-Ferreira MV; Rendo-Urteaga T; Vilanova-Campelo RC; Carvalho HB; da Paz Oliveira G; Paes Landim MB; Torres-Leal FL
Clin Nutr; 2017 Dec; 36(6):1693-1700. PubMed ID: 28081980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
